Bayer, Merck Sign Master Settlement Agreements For Fluoroquinolone MDL Cases

(January 7, 2019, 1:56 PM EST) -- MINNEAPOLIS — The Minnesota federal judge overseeing the fluoroquinolone multidistrict litigation on Jan. 2 said in a pretrial order that defendants Bayer Healthcare Pharmaceuticals Inc. and Merck & Co. Inc. have entered into master settlement agreements to resolve personal injury clams (In Re:  Fluoroquinolone Products Liability Litigation, MDL Docket No. 2642, No. 15-2642, D. Minn.)....

Attached Documents

Related Sections